A randomized phase III study of denosumab before curettage for giant cell tumor of bone (JCOG1610, Preoperative Denosumab for GCTB RPIII)
Phase of Trial: Phase III
Latest Information Update: 01 Apr 2019
Price : $35 *
At a glance
- Drugs Denosumab (Primary)
- Indications Bone cancer; Giant cell tumours
- Focus Therapeutic Use
- 01 Apr 2019 Trial design published in the Japanese Journal of Clinical Oncology
- 23 Oct 2018 According to the trial design data presented at the 43rd European Society for Medical Oncology Congress, the current enrollment is 3 patients in April 2018.
- 23 Oct 2018 Trial design presented at the 43rd European Society for Medical Oncology Congress.